BayCom (BCML) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Net income for Q1 2026 was $8.2 million ($0.75 per diluted share), up from $6.9 million in Q4 2025 and $5.7 million in Q1 2025, driven by higher net interest income, a reversal of provision for credit losses, and increased noninterest income.
Leadership transition announced post-quarter, with new CEO, CFO, and Executive Vice Chair appointed to drive growth and strategic initiatives.
Unusual items, including accretion income, FHLB special dividend, and credit loss reversal, boosted earnings by $0.12 per share.
Financial highlights
Net interest income rose to $25.2 million, up 0.8% sequentially and 10.1% year-over-year.
Annualized net interest margin improved to 4.11% from 4.03% in Q4 2025 and 3.83% in Q1 2025.
Noninterest income increased 74.6% sequentially to $1.5 million, mainly due to equity securities gains and higher loan sale gains.
Noninterest expense rose 2.1% sequentially and 3.2% year-over-year, mainly from higher salaries and benefits.
Provision for income taxes increased to $2.7 million, with an effective tax rate of 25.0%.
Outlook and guidance
Management expects a stronger loan pipeline and improved loan demand in the remainder of 2026, following a challenging Q1.
Leadership transition is intended to support the next phase of growth and expansion in the Western Region.
Latest events from BayCom
- Q4 2025 earnings grew 37% sequentially on higher net interest income and lower credit loss provisions.BCML
Q4 202522 Jan 2026 - Director elections, say-on-pay, and auditor ratification headline a governance-focused agenda.BCML
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with online proxy access.BCML
Proxy Filing2 Dec 2025 - Earnings declined on higher credit loss provisions, but capital and liquidity remain strong.BCML
Q3 20257 Nov 2025 - Q2 2024 net income fell 22% as margins compressed, but capital and deposits remained strong.BCML
Q2 202414 Oct 2025 - Earnings and net interest margin improved, with robust capital and higher nonperforming loans.BCML
Q2 202511 Aug 2025 - Q3 net loss widened to $16.8M; $182.2M cash on hand supports clinical pipeline into 2027.BCML
Q3 202413 Jun 2025 - Q1 2025 net income was $5.7M, with margin gains and robust capital ratios despite higher provisions.BCML
Q1 20256 Jun 2025 - Q4 2024 saw stable earnings, margin improvement, and strong credit quality at BayCom Corp.BCML
Q4 20245 Jun 2025